Document de presse | 2025.05.23
The Health Emergency Preparedness and Response Authority (HERA) of the European Commission, through the European Health and Digital Executive Agency (HaDEA) supports the establishment of the “European Vaccines Hub (EVH) for Pandemic Readiness”, a pan-European center dedicated to advancing public-health–relevant vaccine development. The Grant Agreement has been signed today, marking a...
News | 2025.11.12
A few years ago, measles seemed to be on the verge of being eradicated in many countries. The recent rise in cases raises several questions. Why is measles making a comeback? Is the measles, mumps and rubella (MMR) vaccine safe? Does measles only affect children?
News | 2026.01.20
The Trump administration has falsely suggested, with no scientific basis, that autism is linked to measles vaccination and paracetamol. Leaving aside these highly criticized claims, what are the actual scientific facts about autism spectrum disorder?
News | 2023.07.10
Developing effective therapeutic vaccines requires knowing how to chemically recognize microbes, as well as exposing them to treatment. Able to mutate very quickly and to camouflage itself inside the cells it infects, the AIDS virus (or HIV) constitutes a challenge for researchers.
Article | 2018.07.12
HIV infection remains an outstanding global health issue despite the dramatic progress made over the past 35 years in developing and giving access to prevention and treatment tools. There are still 2 million new infections and 1 million deaths every year. Half of the 37 million people living with HIV do not have access to life-saving antiretroviral treatments. Although these molecules are...
Portrait | 2026.03.30
Guillemette Masse-Ranson, Deputy Director of the Institut Pasteur Vaccinology and Immunotherapy Center, combines industry experience with a passion for academic research. Her ambition is to revolutionize vaccine development by breaking down silos between disciplines, speeding up the transition from lab to clinical practice, and connecting the Institut Pasteur's scientists to international...
News | 2026.04.27
To mark Vaccination Week, and on the initiative of the Institut Pasteur, nearly 300 prominent figures are coming together to emphasise the importance of vaccination and call for a collective response to misinformation and attacks on science and rationality. These men and women come from the fields of scientific research, medicine, culture and media, politics (including numerous health ministers)...
Document de presse | 2025.03.31
After more than 20 years of research on arenaviruses, an Institut Pasteur team led by Sylvain Baize has developed an original vaccine platform known as MOPEVAC, which will strengthen the Institut Pasteur's pandemic preparedness initiatives. A Phase Ia clinical trial led by a research team at the Institut Pasteur is set to begin for the platform's first vaccine candidate, which targets Lassa fever...
Fiche maladie | 2015.10.06
Yellow fever is a viral disease that was first described in the mid-sixteenth century in Yucatán, Mexico. It is caused by yellow fever virus, an arbovirus (a virus transmitted by an insect vector) isolated in 1927, simultaneously in Ghana and at the Institut Pasteur de Dakar, Senegal. The disease is endemic in Africa and in Central and South America. The case fatality rate is high, fluctuating...
Fiche maladie | 2019.06.17
Diphtheria is a disease caused by several Corynebacterium species in the diphtheriae complex. Diphtheria typically manifests as a respiratory infection that causes impairment of the central nervous system, the throat and other organs, resulting in death by suffocation. The cutaneous form of diphtheria infection is more frequent but often less severe. There is an effective vaccine which is...